US EditionGLP-1 Agonists Reduce Recurrent Atrial Fibrillation
Summary by Anti-Aging, Acupuncture and Health News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
GLP-1 Agonists Reduce Recurrent Atrial Fibrillation
SAN DIEGO — Patients with obesity and diabetes are at a substantially reduced risk of having a recurrence of atrial fibrillation (AF) after ablation if they are taking a glucagon-like peptide 1 (GLP-1) receptor agonist vs another diabetes drug, according to an analysis of matched cohorts with 3 years of follow-up. The study was retrospective, […] The post GLP-1 Agonists Reduce Recurrent Atrial Fibrillation first appeared on News Health.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
